Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Mitomycin and BCG in High Risk NMIBC
NCT03790384Phase 4Unknown
- Sponsor
- Sant'Andrea Hospital
- Start
- Jan 2019
- Primary completion
- Sep 2019
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of mitomycin c in Non-muscle-invasive bladder cancer (NMIBC), sponsored by Sant'Andrea Hospital. Status: unknown.
02
Drugs
mitomycin c
03
Conditions
Non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT03790384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03790384.